Wells Fargo’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Wells Fargo's ANRO Position: Q3 2026 in Review
Wells Fargo reduced its Alto Neuroscience (ANRO) stake by 53% in Q3 2026, selling an estimated $422K and leaving 12,241 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #4461.
Wells Fargo first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. The position peaked at $694K in Q2 2026. 116 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Wells Fargo held 12,241 shares of Alto Neuroscience worth $313K as of Q3 2026.
- Wells Fargo sold 14,062 Alto Neuroscience shares in Q3 2026, an estimated $422K.
- Alto Neuroscience made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #4461 holding.
- Wells Fargo first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
- Wells Fargo's Alto Neuroscience position peaked at $694K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.